Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "RMAT"

1989 News Found

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe


NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Opinion | June 10, 2026

NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan

The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India


Remidio secures Gates Foundation grant to advance AI-powered retinal screening
Healthcare | June 10, 2026

Remidio secures Gates Foundation grant to advance AI-powered retinal screening

Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities


FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough
R&D | June 10, 2026

FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough

The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year


OET conducts Kerala workshop series to strengthen healthcare communication training
Healthcare | June 10, 2026

OET conducts Kerala workshop series to strengthen healthcare communication training

Three-city educator training programme equips teachers with practical strategies to improve healthcare English instruction and prepare professionals for global workforce demands


Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide
News | June 09, 2026

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format


Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles
People | June 09, 2026

Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles

Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development


Merck signs MoU with CSIR-IICT to strengthen industry-academia ties
R&D | June 09, 2026

Merck signs MoU with CSIR-IICT to strengthen industry-academia ties

The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation


Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Healthcare | June 09, 2026

Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours

Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology